Logo image of PBHC

PATHFINDER BANCORP INC (PBHC) Stock Fundamental Analysis

USA - NASDAQ:PBHC - US70319R1095 - Common Stock

15.06 USD
-0.04 (-0.26%)
Last: 11/7/2025, 8:07:04 PM
Fundamental Rating

2

Overall PBHC gets a fundamental rating of 2 out of 10. We evaluated PBHC against 388 industry peers in the Banks industry. PBHC may be in some trouble as it scores bad on both profitability and health. PBHC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PBHC had positive earnings in the past year.
PBHC had a positive operating cash flow in the past year.
In the past 5 years PBHC has always been profitable.
Each year in the past 5 years PBHC had a positive operating cash flow.
PBHC Yearly Net Income VS EBIT VS OCF VS FCFPBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1.2 Ratios

PBHC has a worse Return On Assets (0.11%) than 87.69% of its industry peers.
The Return On Equity of PBHC (1.39%) is worse than 87.18% of its industry peers.
Industry RankSector Rank
ROA 0.11%
ROE 1.39%
ROIC N/A
ROA(3y)0.46%
ROA(5y)0.51%
ROE(3y)5.73%
ROE(5y)6.23%
ROIC(3y)N/A
ROIC(5y)N/A
PBHC Yearly ROA, ROE, ROICPBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 3.41%, PBHC is doing worse than 87.44% of the companies in the same industry.
PBHC's Profit Margin has declined in the last couple of years.
PBHC does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 3.41%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.58%
PM growth 5Y-14.02%
GM growth 3YN/A
GM growth 5YN/A
PBHC Yearly Profit, Operating, Gross MarginsPBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1

2. Health

2.1 Basic Checks

PBHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PBHC has more shares outstanding
PBHC has more shares outstanding than it did 5 years ago.
PBHC has a worse debt/assets ratio than last year.
PBHC Yearly Shares OutstandingPBHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
PBHC Yearly Total Debt VS Total AssetsPBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

PBHC has a debt to FCF ratio of 5.01. This is a neutral value as PBHC would need 5.01 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.01, PBHC is doing worse than 69.49% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that PBHC is not too dependend on debt financing.
The Debt to Equity ratio of PBHC (0.38) is worse than 73.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 5.01
Altman-Z N/A
ROIC/WACCN/A
WACC17.96%
PBHC Yearly LT Debt VS Equity VS FCFPBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
PBHC Yearly Current Assets VS Current LiabilitesPBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2

3. Growth

3.1 Past

The earnings per share for PBHC have decreased strongly by -74.57% in the last year.
PBHC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.05% yearly.
The Revenue has grown by 16.23% in the past year. This is quite good.
Measured over the past years, PBHC shows a quite strong growth in Revenue. The Revenue has been growing by 8.80% on average per year.
EPS 1Y (TTM)-74.57%
EPS 3Y-38.16%
EPS 5Y-12.05%
EPS Q2Q%-98.39%
Revenue 1Y (TTM)16.23%
Revenue growth 3Y4.32%
Revenue growth 5Y8.8%
Sales Q2Q%-13.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PBHC Yearly Revenue VS EstimatesPBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2

4. Valuation

4.1 Price/Earnings Ratio

PBHC is valuated quite expensively with a Price/Earnings ratio of 53.79.
Based on the Price/Earnings ratio, PBHC is valued more expensive than 86.15% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.06, PBHC is valued quite expensively.
Industry RankSector Rank
PE 53.79
Fwd PE N/A
PBHC Price Earnings VS Forward Price EarningsPBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, PBHC is valued cheaply inside the industry as 82.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.73
EV/EBITDA N/A
PBHC Per share dataPBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

PBHC has a Yearly Dividend Yield of 2.65%. Purely for dividend investing, there may be better candidates out there.
PBHC's Dividend Yield is comparable with the industry average which is at 3.38.
PBHC's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.65%

5.2 History

The dividend of PBHC is nicely growing with an annual growth rate of 7.64%!
PBHC has been paying a dividend for at least 10 years, so it has a reliable track record.
PBHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.64%
Div Incr Years4
Div Non Decr Years14
PBHC Yearly Dividends per sharePBHC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

144.55% of the earnings are spent on dividend by PBHC. This is not a sustainable payout ratio.
PBHC's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP144.55%
EPS Next 2YN/A
EPS Next 3YN/A
PBHC Yearly Income VS Free CF VS DividendPBHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
PBHC Dividend Payout.PBHC Dividend Payout, showing the Payout Ratio.PBHC Dividend Payout.PayoutRetained Earnings

PATHFINDER BANCORP INC

NASDAQ:PBHC (11/7/2025, 8:07:04 PM)

15.06

-0.04 (-0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-29 2025-10-29
Earnings (Next)01-29 2026-01-29
Inst Owners22.32%
Inst Owner Change-0.09%
Ins Owners13.31%
Ins Owner Change1.47%
Market Cap72.14M
Revenue(TTM)50.63M
Net Income(TTM)1.73M
Analysts0
Price TargetN/A
Short Float %0.11%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield 2.65%
Yearly Dividend0.4
Dividend Growth(5Y)7.64%
DP144.55%
Div Incr Years4
Div Non Decr Years14
Ex-Date10-17 2025-10-17 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 53.79
Fwd PE N/A
P/S 1.42
P/FCF 7.73
P/OCF 6.47
P/B 0.58
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)0.28
EY1.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.95
FCFY12.94%
OCF(TTM)2.33
OCFY15.45%
SpS10.57
BVpS25.97
TBVpS23.73
PEG (NY)N/A
PEG (5Y)N/A
Graham Number12.79
Profitability
Industry RankSector Rank
ROA 0.11%
ROE 1.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.41%
GM N/A
FCFM 18.44%
ROA(3y)0.46%
ROA(5y)0.51%
ROE(3y)5.73%
ROE(5y)6.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.58%
PM growth 5Y-14.02%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 5.01
Debt/EBITDA N/A
Cap/Depr 96.08%
Cap/Sales 3.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 540.85%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC17.96%
ROIC/WACCN/A
Cap/Depr(3y)248.61%
Cap/Depr(5y)177.19%
Cap/Sales(3y)6.52%
Cap/Sales(5y)5.11%
Profit Quality(3y)236.67%
Profit Quality(5y)350.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-74.57%
EPS 3Y-38.16%
EPS 5Y-12.05%
EPS Q2Q%-98.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.23%
Revenue growth 3Y4.32%
Revenue growth 5Y8.8%
Sales Q2Q%-13.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.96%
FCF growth 3Y-21.54%
FCF growth 5Y15.14%
OCF growth 1Y-32.93%
OCF growth 3Y-17.76%
OCF growth 5Y6.66%

PATHFINDER BANCORP INC / PBHC FAQ

What is the fundamental rating for PBHC stock?

ChartMill assigns a fundamental rating of 2 / 10 to PBHC.


What is the valuation status of PATHFINDER BANCORP INC (PBHC) stock?

ChartMill assigns a valuation rating of 2 / 10 to PATHFINDER BANCORP INC (PBHC). This can be considered as Overvalued.


How profitable is PATHFINDER BANCORP INC (PBHC) stock?

PATHFINDER BANCORP INC (PBHC) has a profitability rating of 2 / 10.


Can you provide the financial health for PBHC stock?

The financial health rating of PATHFINDER BANCORP INC (PBHC) is 1 / 10.


Is the dividend of PATHFINDER BANCORP INC sustainable?

The dividend rating of PATHFINDER BANCORP INC (PBHC) is 5 / 10 and the dividend payout ratio is 144.55%.